Application of artificial intelligence in drug development and patient care: An editorial overview

References

1. Visan AI, Negut I. Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery. Life. 2024;14(2):1–36. doi: 10.3390/life14020233
   [Google Scholar]
2. Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine. Pharmaceutics. 2024;16(10):1–27. doi: 10.3390/ pharmaceutics16101328.
3. Fitria TN. Artificial intelligence (AI) in education: Using AI tools for teaching and learning process. In: Prosiding seminar nasional & call for paper STIE AAS. Surakarta, Jawa Tengah; 2021. p–134–147.
4. Lamberti MJ, Wilkinson M, Donzanti BA, Wohlhieter GE, Parikh S, Wilkins RG, Getz K. A study on the application and use of artificial intelligence to support drug development. Clin Ther. 2019; 41(8):1414–26. doi: 10.1016/j.clinthera.2019.05.018
   [Google Scholar]
5. Tiwari PC, Pal R, Chaudhary MJ, Nath R. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges. Drug Dev Res. 2023; 84(8):1652–1663. doi: 10.1002/ ddr.22115.
6. Kamila MK, Jasrotia SS. Ethical issues in the development of artificial intelligence: recognizing the risks. Int. J. Ethics Syst. 2025;41(1):45–63.
7. Han R, Yoon H, Kim G, Lee H, Lee Y. Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery. Pharmaceuticals (Basel). 2023; 16(9):1–34. doi: 10.3390/ph16091259
   [Google Scholar]
8. Blanco-Gonzalez A., Cabezon A, Seco-Gonzalez A, Conde-Torres D, Antelo-Riveiro P, Pineiro A, Garcia-Fandino R. The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals(Basel). 2023; 16(6):1–11. doi: 10.3390/ ph16060891.
9. Vatansever S, Schlessinger A, Wacker D, Kaniskan HÜ, Jin J, Zhou MM, et al. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Med Res Rev. 2021;41(3):1427-73. doi: 10.1002/ med.21764.
10. Gupta U, Pranav A, Kohli A, Ghosh S, Singh D. The contribution of artificial intelligence to drug discovery: Current progress and prospects for the future. In: Microbial data intelligence and computational techniques for sustainable computing. 2024. p. 1–23. doi:10.1007/978-981-99-9621-6_1
    [Google Scholar]
11. Verma A, Awasthi A. Revolutionizing drug discovery: the role of artificial intelligence and machine learning. Curr Pharm Des. 2024;30(11):807–10. doi: 10.2174/0113816128298691240222054120
    [Google Scholar]
12. Zhang K, Yang X, Wang Y, Yu Y, Huang N, Li G, et al. Artificial intelligence in drug development. Nat Med. 2025; 31(1), 45–59. doi: 10.1038/s41591-024-03434-4
    [Google Scholar] Tripathy et al. / Indian Journal of Pharmacy and Pharmacology 2025;12(3):126–128 128
13. Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. 2021; Mol Divers. 25(3), 1315–1360. doi: 10.1007/s11030-021-10217-3
    [Google Scholar]
14. Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, Vale N. Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics. 2024;16(3):1–39.
15. Selvaraj C, Chandra I, Singh SK. Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Mol Divers. 2022; 26(3):1893-1913. doi: 10.1007/s11030-021-10326-z
    [Google Scholar]
16. Qureshi R, Irfan M, Gondal TM, Khan S, Wu J, Hadi MU, et al. AI in drug discovery and its clinical relevance. Heliyon. 2023;9(7):1–23. doi: 10.1016/j.heliyon.2023.e17575
    [Google Scholar]
17. Blanco-Gonzalez A, Cabezon A, Seco-Gonzalez A, Conde-Torres D, Antelo-Riveiro P, Pineiro A, et al. The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals (Basel). 2023;16(6):1–11. doi: 10.3390/ph16060891
    [Google Scholar]
18. Parvatikar PP, Patil S, Khaparkhuntikar K, Patil S, Singh PK, Sahana R, et al. Artificial intelligence: Machine learning approach for screening large database and drug discovery. Antiviral Res. 2023;220,105740. doi: 10.1016/j.antiviral.2023.105740
    [Google Scholar]
19. Mak KK, Wong YH, Pichika MR. Artificial intelligence in drug discovery and development. In: Drug discovery and evaluation: safety and pharmacokinetic assays. 2024 p. 1461–1498. doi:10.1007/978-3-031-35529-5_92
    [Google Scholar]
20. Jena BR, Swain SK, Ghose D. Artificial intelligence (A.I), Robotics & Computational Fluid Dynamics. In: Computer aided drug development. 1st Ed. Wood Head Publishing India Pvt. Ltd; 2022. pp. 1–170.